ATE543512T1 - Verwendung von impfstoffen zur behandlung/prävention der übertragung von influenza-erregern zwischen spezies - Google Patents
Verwendung von impfstoffen zur behandlung/prävention der übertragung von influenza-erregern zwischen speziesInfo
- Publication number
- ATE543512T1 ATE543512T1 AT06836580T AT06836580T ATE543512T1 AT E543512 T1 ATE543512 T1 AT E543512T1 AT 06836580 T AT06836580 T AT 06836580T AT 06836580 T AT06836580 T AT 06836580T AT E543512 T1 ATE543512 T1 AT E543512T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccines
- treat
- prevent inter
- species transmission
- influenza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73099805P | 2005-10-28 | 2005-10-28 | |
PCT/US2006/041989 WO2007053446A2 (en) | 2005-10-28 | 2006-10-27 | Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE543512T1 true ATE543512T1 (de) | 2012-02-15 |
Family
ID=38006396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06836580T ATE543512T1 (de) | 2005-10-28 | 2006-10-27 | Verwendung von impfstoffen zur behandlung/prävention der übertragung von influenza-erregern zwischen spezies |
Country Status (12)
Country | Link |
---|---|
US (1) | US8883123B2 (de) |
EP (1) | EP1942924B1 (de) |
JP (1) | JP2009513667A (de) |
KR (1) | KR20080065680A (de) |
CN (2) | CN102406932A (de) |
AR (1) | AR056733A1 (de) |
AT (1) | ATE543512T1 (de) |
AU (1) | AU2006309007A1 (de) |
BR (1) | BRPI0617952A2 (de) |
CA (1) | CA2626866A1 (de) |
TW (1) | TW200731986A (de) |
WO (1) | WO2007053446A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883123B2 (en) | 2005-10-28 | 2014-11-11 | Boehringer Ingleheim Vetmedica, Inc. | Use of vaccines for the treatment/prevention of the transmission of pathogens |
US8202967B2 (en) * | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
US20090246226A1 (en) * | 2008-03-28 | 2009-10-01 | Zeon Corporation | Avian vaccines possessing a positive marker gene |
DE102008002641A1 (de) * | 2008-06-25 | 2009-12-31 | Biotronik Vi Patent Ag | Faserstrang und implantierbarer Stützkörper mit einem Faserstrang |
EP2329845A4 (de) * | 2008-08-18 | 2013-08-14 | Kitasato Daiichi Sankyo Vaccine Co Ltd | Vogelgrippevirus-antigen und boosterimmunisierungsverfahren für vogelgrippeimpfstoff in kombination mit einem mukosalen adjuvans mit wirksamkeit durch orale verabreichung |
KR20110092316A (ko) * | 2008-11-19 | 2011-08-17 | 래보래토리오 아비-멕스, 에스.에이. 데 씨.브이. | 재조합 불활성화 바이러스 벡터 백신 |
MX2011005604A (es) | 2008-11-28 | 2011-09-01 | Merial Ltd | Vacuna recombinante para influenza aviar y sus usos. |
AR088028A1 (es) * | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
MX360137B (es) * | 2013-02-21 | 2018-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Proteínas h5 del virus de la influenza h5n1 para usarse como un medicamento. |
ES2739123T3 (es) | 2013-08-28 | 2020-01-29 | Glaxosmithkline Biologicals Sa | Nuevos antígenos y anticuerpos de la gripe |
MX2021005257A (es) * | 2018-11-06 | 2021-06-18 | Boehringer Ingelheim Vetmedica Gmbh | Composicion inmunogenica contra el subtipo h5 del virus de la influenza aviar. |
MX2019014943A (es) | 2018-12-12 | 2020-08-06 | Cambridge Tech Llc | Vacuna universal contra la gripe. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552758A (en) | 1983-12-20 | 1985-11-12 | St. Jude Children's Research Hospital | Human use of avian-human reassortants as vaccines for influenza A virus |
US6204281B1 (en) | 1998-07-10 | 2001-03-20 | Novartis Ag | Method of treatment and pharmaceutical composition |
WO2002062381A1 (fr) | 2001-02-05 | 2002-08-15 | Hisamitsu Pharmaceutical Co., Inc. | Vaccin a vecteur de baculovirus |
EP1413315A4 (de) | 2001-08-03 | 2006-08-16 | Takeda Pharmaceutical | Medikamente mit verzögerter freisetzung |
EP2581093B1 (de) | 2003-06-16 | 2015-03-18 | MedImmune, LLC | Influenza-Hämagglutinin- und Neuraminidase-Varianten |
EP1722815A1 (de) * | 2004-03-09 | 2006-11-22 | Chiron Corporation | Influenza-virus-vakzine |
CN1748795A (zh) | 2004-09-17 | 2006-03-22 | 金宁一 | 多价禽流感重组活载体疫苗 |
KR20060089393A (ko) * | 2005-02-04 | 2006-08-09 | 주식회사 중앙백신연구소 | 돼지 인플루엔자 바이러스a/swine/korea/s83/2004(h9n2) 및 이의백신 |
KR20080052509A (ko) | 2005-04-11 | 2008-06-11 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 | 유행성 독감 바이러스에 대한 백신 |
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
US8883123B2 (en) | 2005-10-28 | 2014-11-11 | Boehringer Ingleheim Vetmedica, Inc. | Use of vaccines for the treatment/prevention of the transmission of pathogens |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
-
2006
- 2006-10-27 US US11/553,492 patent/US8883123B2/en active Active
- 2006-10-27 AU AU2006309007A patent/AU2006309007A1/en not_active Abandoned
- 2006-10-27 WO PCT/US2006/041989 patent/WO2007053446A2/en active Application Filing
- 2006-10-27 AR ARP060104694A patent/AR056733A1/es not_active Withdrawn
- 2006-10-27 BR BRPI0617952-5A patent/BRPI0617952A2/pt not_active IP Right Cessation
- 2006-10-27 KR KR1020087012894A patent/KR20080065680A/ko not_active Application Discontinuation
- 2006-10-27 CA CA002626866A patent/CA2626866A1/en not_active Abandoned
- 2006-10-27 AT AT06836580T patent/ATE543512T1/de active
- 2006-10-27 CN CN2011103839490A patent/CN102406932A/zh active Pending
- 2006-10-27 TW TW095139655A patent/TW200731986A/zh unknown
- 2006-10-27 JP JP2008537991A patent/JP2009513667A/ja active Pending
- 2006-10-27 EP EP06836580A patent/EP1942924B1/de active Active
- 2006-10-27 CN CNA2006800400455A patent/CN101300023A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20070207168A1 (en) | 2007-09-06 |
JP2009513667A (ja) | 2009-04-02 |
KR20080065680A (ko) | 2008-07-14 |
CN102406932A (zh) | 2012-04-11 |
CA2626866A1 (en) | 2007-05-10 |
WO2007053446A3 (en) | 2007-08-16 |
AU2006309007A8 (en) | 2008-06-19 |
TW200731986A (en) | 2007-09-01 |
WO2007053446A2 (en) | 2007-05-10 |
CN101300023A (zh) | 2008-11-05 |
AU2006309007A1 (en) | 2007-05-10 |
US8883123B2 (en) | 2014-11-11 |
BRPI0617952A2 (pt) | 2011-08-09 |
EP1942924B1 (de) | 2012-02-01 |
AR056733A1 (es) | 2007-10-17 |
EP1942924A2 (de) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE543512T1 (de) | Verwendung von impfstoffen zur behandlung/prävention der übertragung von influenza-erregern zwischen spezies | |
ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
ATE545418T1 (de) | Zusammensetzungen und kits zur behandlung von influenza | |
DE202012013074U8 (de) | Zusammensetzungen zur Behandlung von HCV | |
ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
DK2796469T3 (da) | Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser | |
ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
ATE521352T1 (de) | Verwendung von flibanserin zur behandlung von prämenopausalen störungen der sexuellen lust | |
DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
ATE490825T1 (de) | Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation | |
DK2236149T3 (da) | Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme | |
ATE532507T1 (de) | Neramexane zur behandlung von subakuten tinnitus | |
BRPI0919004A2 (pt) | composto de multiheteroarila como inibidores de h-pgds e sua utilização para o tratamento de doenças mediadas por prostaglandina d2 | |
ATE533774T1 (de) | Neuartige nukleosidanaloge zur behandlung von virusinfektionen | |
ATE512948T1 (de) | Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen | |
EA200971141A1 (ru) | Соединения, активирующие теломеразу, и способы их применения | |
DE502006007982D1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
DE602007008494D1 (de) | Verwendung von Agomelatin zur Herstellung von Medikamenten zur Behandlung der generalisierten Angststörung | |
ATE483460T1 (de) | Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut | |
DE602008000403D1 (de) | Behandlung von medizinischen Implantaten, die kalkbeständig sind | |
DE602006021192D1 (de) | Visnadin zur Behandlung von Kopfhautjucken | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen |